Mirae Asset Global ETFs Holdings’s INmune Bio INMB Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio INMB Stock Details INMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11.5K	Buy	10,205 +238	+2%	+$339	﹤0.01%	3068
2025 Q4	$15.5K	Buy	9,967 +2,453	+33%	+$4.38K	﹤0.01%	3061
2025 Q3	$15.6K	Sell	7,514 -1,604	-18%	-$3.67K	﹤0.01%	3062
2025 Q2	$21.1K	Buy	9,118 +1,078	+13%	+$7.91K	﹤0.01%	2964
2025 Q1	$62.8K	Buy	8,040 +312	+4%	+$2.48K	﹤0.01%	2801
2024 Q4	$36.1K	Buy	7,728 +919	+13%	+$4.79K	﹤0.01%	2948
2024 Q3	$36.7K	Buy	+6,809	New	+$48.4K	﹤0.01%	2969

Other funds holding INMB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's INMB Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its INmune Bio (INMB) stake by 2.4% in Q1 2026, buying an estimated $339 and bringing the position to 10,205 shares worth $11.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3068.

Mirae Asset Global ETFs Holdings first reported a position in INMB in Q3 2024 and has held it in 7 quarters since. The position peaked at $62.8K in Q1 2025. 82 funds tracked by Wall St. Rank hold INMB as of Q1 2026.

Mirae Asset Global ETFs Holdings held 10,205 shares of INmune Bio worth $11.5K as of Q1 2026.
Mirae Asset Global ETFs Holdings bought 238 INmune Bio shares in Q1 2026, an estimated $339.
INmune Bio made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #3068 holding.
Mirae Asset Global ETFs Holdings first reported a position in INmune Bio in Q3 2024 and has held it in 7 quarters since.
Mirae Asset Global ETFs Holdings's INmune Bio position peaked at $62.8K in Q1 2025.
82 funds tracked by Wall St. Rank held INmune Bio as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.